Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Mobilized PB-MNC for No-Option CLI
NCT03686228Unknown
- Sponsor
- Mahidol University
- Start
- Oct 2018
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial in critical limb ischemia (CLI) (2 arms), sponsored by Mahidol University. Primary endpoint: Amputation Free Survival at 3 months. Status: unknown.
02
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03686228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686228.